Learn More
Invitrogen™ PAFAH1B2 Polyclonal Antibody

Description
Recommended positive controls: HepG2, NIH-3T3, JC. Predicted reactivity: Mouse (100%), Rat (100%), Xenopus laevis (86%), Chicken (93%), Rhesus Monkey (100%), Bovine (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | PAFAH1B2 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | PAFAH1B2 |
| Gene Accession No. | P68402, Q61206 |
| Gene Alias | AI747451; AU021353; epididymis secretory protein Li 303; HEL-S-303; intracellular platelet-activating factor acetylhydrolase alpha 2 subunit; mus[b]; PAF acetylhydrolase 30 kDa subunit; PAF-AH 30 kDa subunit; PAF-AH alpha 2; PAFAH subunit beta; PAF-AH subunit beta; PAF-AH1b alpha 2 subunit; Pafah1b2; Pafahb; pl; platelet activating factor acetylhydrolase 1b catalytic subunit 2; platelet-activating factor acetylhydrolase 1b, catalytic subunit 2; platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa); Platelet-activating factor acetylhydrolase alpha 2 subunit; platelet-activating factor acetylhydrolase alpha 2 subunit (PAF-AH alpha 2); platelet-activating factor acetylhydrolase IB subunit beta; platelet-activating factor acetylhydrolase, isoform 1b, alpha2 subunit; platelet-activating factor acetylhydrolase, isoform 1b, subunit 2; platelet-activating factor acetylhydrolase, isoform Ib, beta subunit; platelet-activating factor acetylhydrolase, isoform Ib, subunit 2; platelet-activating factor acetylhydrolase, isoform Ib, subunit 2 (30kDa) |
| Gene Symbols | PAFAH1B2 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.